COMMUNIQUÉS West-GlobeNewswire

Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke

27/03/2025 - 13:00

SAN MATEO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today [...]

Vivani Medical Announces $8.25M Private Placement Equity Financing

27/03/2025 - 12:32

Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated development of NPM-139, Company’s once or twice-yearly GLP-1 (semaglutide) implant under development for [...]

Bicara Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

27/03/2025 - 12:30

Dosing commenced in FORTIFI-HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting Strong financial [...]

PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update

27/03/2025 - 12:30

Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune ® HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., March 27, 2025 (GLOBE [...]

Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update

27/03/2025 - 12:30

154 patients enrolled TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic [...]

Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

27/03/2025 - 12:30

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing [...]

Immatics Announces Full Year 2024 Financial Results and Business Update

27/03/2025 - 12:00

Randomized-controlled Phase 3 trial, SUPRAME, to evaluate ACTengine® IMA203 TCR-T (PRAME) in advanced melanoma patients; first patient randomized and enrollment continues as planned ACTengine® IMA203 TCR-T (PRAME): [...]

EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

27/03/2025 - 12:00

WATERTOWN, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]

BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference

27/03/2025 - 12:00

The presentation will be webcast at 1:30 PM ET on April 10, 2025 POMPANO BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, [...]

TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access

27/03/2025 - 12:00

Mr. Camiolo brings to TScan demonstrated commercial readiness and cell therapy launch experience WALTHAM, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology [...]

Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

27/03/2025 - 12:00

– Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially first-in-class blocking [...]

Microbix Announces Annual and Special Meeting Voting Results

27/03/2025 - 12:00

MISSISSAUGA, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQB: MBXBF ) (“ Microbix® ” or the “ Company ”), a life sciences innovator and exporter, announces the voting results from [...]

Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update

27/03/2025 - 12:00

First Analysis from Phase 1b Study of GT-02287 in Parkinson’s Disease Expected in Q2 2025 BETHESDA, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical- [...]

BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones

27/03/2025 - 12:00

Plinabulin Final Phase 3 Data Published in The Lancet Respiratory Medicine , Demonstrating Overall Survival Benefit in 2L/3L NSCLC EGFR Wild Type vs. Docetaxel Plinabulin Phase 2 Data Highlights Potential to Resensitize [...]

Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference

27/03/2025 - 11:30

Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary Perforations WAYNE, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical [...]

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

27/03/2025 - 11:00

STAFFORD, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]

Arialief Nerve Health Supplement Review: Benefits, Side Effects & Where to Buy

27/03/2025 - 10:59

AURORA, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Nerve health has become a critical concern for many individuals suffering from conditions such as neuropathy, sciatica, and other forms of chronic nerve discomfort. [...]

Zelluna ASA [ZLNA]: Share capital increase registered

27/03/2025 - 10:21

Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 26 March 2025 regarding the resolution of the board of directors of Zelluna ASA (the " Company ") to carry out a share capital [...]

LE QUÉBEC RATE UNE OCCASION DE GÉNÉRER DES REVENUS POUR LA SANTÉ PUBLIQUE

27/03/2025 - 10:00

MONTRÉAL, 27 mars 2025 (GLOBE NEWSWIRE) -- Avec déception, le Collectif Vital a constaté que le financement de la santé publique accuse un recul dans le budget 2025-2026 du ministre des Finances. La taxation des [...]